{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:42:24Z","timestamp":1771890144066,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":247,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-006488"],"award-info":[{"award-number":["INV-006488"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception: X"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.conx.2023.100100","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T07:02:19Z","timestamp":1694502139000},"page":"100100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9791-2222","authenticated-orcid":false,"given":"Vera","family":"Halpern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angie","family":"Wheeless","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Brache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Lendvay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Coch\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laneta J.","family":"Dorflinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.conx.2023.100100_bib1","unstructured":"United Nations, Department of Economics and Social Affairs. Contraceptive use by method\u00a02019. \u3008https:\/\/www.un.org\/development\/desa\/pd\/sites\/www.un.org.development.desa.pd\/files\/files\/documents\/2020\/Jan\/un_2019_contraceptiveusebymethod_databooklet.pdf\u3009. Accessed March 20, 2023."},{"key":"10.1016\/j.conx.2023.100100_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40834-016-0019-0","article-title":"Characteristics and contributory factors for injectable contraceptive usage among women in Kumasi, Ghana","volume":"1","author":"Laryea","year":"2016","journal-title":"Contracept Reprod Med"},{"key":"10.1016\/j.conx.2023.100100_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217333","article-title":"Potential user interest in new long-acting contraceptives: results from a mixed methods study in Burkina Faso and Uganda","volume":"14","author":"Callahan","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.conx.2023.100100_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2009.02.005","article-title":"Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density","volume":"80","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.conx.2023.100100_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.conx.2023.100100_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.contraception.2009.03.005","article-title":"Inhibitory effects of progestogens on the estrogen stimulation of melanocytes in vitro","volume":"80","author":"Wiedemann","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.conx.2023.100100_bib7","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.15104","article-title":"Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors","volume":"5","author":"Natale","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.conx.2023.100100_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101273","article-title":"Contraceptive effectiveness, pharmacokinetics, and safety of Sayana\u00ae Press when injected every four months: a multicenter phase 3 trial","volume":"44","author":"Deese","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.conx.2023.100100_bib9","unstructured":"Pfizer. Package insert: Depo-Provera 400 mg\/mL. 2017. \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/012541s086lbl.pdf\u3009. Accessed August 16, 2023."}],"container-title":["Contraception: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590151623000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590151623000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:33:59Z","timestamp":1762914839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590151623000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":9,"alternative-id":["S2590151623000126"],"URL":"https:\/\/doi.org\/10.1016\/j.conx.2023.100100","relation":{},"ISSN":["2590-1516"],"issn-type":[{"value":"2590-1516","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation","name":"articletitle","label":"Article Title"},{"value":"Contraception: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conx.2023.100100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100100"}}